Instrumental chemistry

Global GC Systems Market Valued at $3.1 Billion in 2023, Driven by Pharmaceutical Sector's Growing Need for Purity Analysis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 26, 2023
Health, Pharmaceutical, Medicine, Framework, Drug development, Food safety, Autosampler, Agriculture, Gas chromatography, Organic compound, The Queen's Award for Enterprise: Innovation (Technology) (2007), Merck Group, Volatile organic compound, VOC, Cosmetics, Element, Gas, GC-MS, LECO Corporation, Agilent Technologies, Ionic liquid, United Kingdom, Instrumental chemistry, ILS, Growth, Atomic mass, Polysorbate, GC, OI, FORDA-MOF, Peptide, Renewable energy, Perfume

The global market for GC Systems is set to reach new heights, with an estimated valuation of US$3.1 billion in 2023, and further projected to soar to US$4.4 billion by 2029.

Key Points: 
  • The global market for GC Systems is set to reach new heights, with an estimated valuation of US$3.1 billion in 2023, and further projected to soar to US$4.4 billion by 2029.
  • Pharmaceutical Sector Leading the Way: The pharmaceutical sector, already the largest end-use sector for GC Systems, is expected to maintain its position as the fastest-growing segment.
  • Diverse Product Segments: The GC Systems market includes various product segments, such as instruments, autosamplers, detectors, fraction collectors, and consumables & accessories.
  • Food Safety: GC Systems coupled with other technologies are simplifying the separation and analysis of food-borne pesticides, contributing to food safety.

Avalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Retrieved on: 
Wednesday, July 19, 2023
Aetna, CAP, COVID-19, Genex Power, Genetic testing, Cigna, National Health Laboratory Service, Medicare, LSM, MSA, Laboratory, Master service agreement, Others, LC-MS, Instrumental chemistry, MSO, UnitedHealth Group, Toxicology testing, Pharmaceutical industry, Medicaid

FREEHOLD, N.J., July 19, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC (“LSM”), has signed an exclusive Master Service Agreement (“MSA”) with GeneX Laboratory Professional Corp. (“GeneX”). Avalon owns a 40% interest in LSM.

Key Points: 
  • Genex is a CLIA-certified and CAP-accredited laboratory located in Orange County, California that has been dormant and seeking a partner to utilize their valuable license networks.
  • Those tests will now be performed utilizing the LSM infrastructure and resources providing significant expansion opportunity for LSM to perform services through in-network insurance providers previously unavailable.
  • GeneX provides top-tier, comprehensive laboratory testing services and works with major providers in addition to Medicaid in 21 states.
  • By leveraging LSM’s experience and infrastructure, we expect to achieve significant synergies with respect to revenue growth and market shares,” concluded Dr. Jin.

MOBILion Systems to Expand Applications of SLIM Separation Technology with License to TOFWERK AG

Retrieved on: 
Thursday, May 18, 2023
American Society for Mass Spectrometry, Aerosol, ASMS, SLIM, Mass spectrometry, Gas, Organic compound, Structures for lossless ion manipulations, Volatile organic compound, Unresolved complex mixture, LC-MS, Instrumental chemistry, Society

CHADDS FORD, Pa., May 18, 2023 /PRNewswire/ -- MOBILion Systems Inc. and Thun, Switzerland-based TOFWERK AG have announced a sublicensing agreement for the development of an ion mobility/time-of-flight (TOF) mass spectrometry product based on Structures for Lossless Ion Manipulation (SLIM) separation technology.

Key Points: 
  • CHADDS FORD, Pa., May 18, 2023 /PRNewswire/ -- MOBILion Systems Inc. and Thun, Switzerland-based TOFWERK AG have announced a sublicensing agreement for the development of an ion mobility/time-of-flight (TOF) mass spectrometry product based on Structures for Lossless Ion Manipulation (SLIM) separation technology.
  • TOFWERK provides innovative solutions for chemical analysis, developing time-of-flight mass spectrometers for applications that demand exceptional speed and sensitivity.
  • "We are excited to be able to expand applications and continue to demonstrate the impact of the SLIM platform technology more broadly.
  • TOFWERK's expertise in this market will accelerate the implementation of the SLIM technology to address customers' needs in volatile compound analysis."

BCAL DIAGNOSTICS OPENS NEW LABORATORY IN SYDNEY AS IT ACCELERATES DEVELOPMENT OF ITS BREAST CANCER BLOOD SCREENING TOOL

Retrieved on: 
Thursday, May 4, 2023
LDT, Therapeutic Goods Administration, Accreditation, ISO, Lipid, Woman, ASX, Research, Plasma, CLIA, LCMS, Patient, Algorithm, Instrumental chemistry, Therapeutic Goods Act 1989, BCAL, BDX, Breast cancer, Medical device, Medical imaging

SYDNEY, May 4, 2023 /PRNewswire/ -- BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) an Australian-based biotechnology company announced the opening of its development and clinical service laboratory in Sydney. This step marks an important milestone for the company as it advances commercialization of its non-invasive blood screening that is initially intended to be used alongside other breast cancer screening methods, with results to date demonstrating 91% sensitivity and 80% specificity. The technology will initially complement current imaging technologies, such as the mammogram, while BCAL further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location.

Key Points: 
  • SYDNEY, May 4, 2023 /PRNewswire/ -- BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) an Australian-based biotechnology company announced the opening of its development and clinical service laboratory in Sydney.
  • Patient samples will be collected and forwarded to BCAL's laboratory, where they will be tested for the proprietary BCAL lipid signature that is expressed by breast cancer cells.
  • "We plan to use this laboratory for a variety of purposes leading up to and following product approval and availability.
  • To learn more about BCAL Diagnostics or to participate in BCAL's research, you can register your interest online at www.bcaldiagnostics.com .

Foresees the Future Trend of Laboratory Technology

Retrieved on: 
Monday, September 27, 2021
Artificial intelligence, Efficiency, Solution, Instrumental chemistry, Conference, Digital technology, Beijing, CEO, AR, Technology, Exhibition, Automation, Research, Big data, Laboratory, Augment, Augmented reality, Medical device, Instrumentation

BEIJING, Sept. 27, 2021 /PRNewswire/ -- On September 27, 2021, NIKYANG made a stunning appearance at the 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) with its latest innovative laboratory automation solutions that are essentially used for the drug R&D analysis and sample preparation of Chinese and Western medicines.

Key Points: 
  • This year, NIKYANG has gone beyond the ordinary booth environment and deployed AR (Augmented Reality) technology to amplify its message and fascinate audiences in a better and differentiated brand experience.
  • Eric Wong, CEO and founder of NIKYANG, added, "In the era of big data and artificial intelligence, laboratory automation is imperative.
  • Laboratory automation technology is already matured in the European and the United States markets.
  • Though hindrances still remain in the development of lab digitization, NIKYANG will continue to devote its expertise to reform laboratories by embracing advanced digital technology and laboratory automation.

Outlook on the Process Analytical Technology Global Market to 2025 - Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis

Retrieved on: 
Friday, April 9, 2021
Natural sciences, Physical sciences, Chemistry, Chromatography, Electrophoresis, Materials science, Analytical chemistry, Capillary electrophoresis, Polymerase chain reaction, Thermal analysis, Agilent Technologies, Instrumental chemistry

However, the high cost involved in the process of PAT (Process Analytical Technology) deployment and a dearth of skilled professionals are expected to hamper the market growth to a certain extent.

Key Points: 
  • However, the high cost involved in the process of PAT (Process Analytical Technology) deployment and a dearth of skilled professionals are expected to hamper the market growth to a certain extent.
  • Also, loopholes in the infrastructural sector in developing economies may create hindrances in the growth of the Global Process Analytical Technology Market.
  • The Global Process Analytical Technology Market is segmented further based on Technique, Measurements, End Users, Products & Services, and Geography.
  • By Technique, the market is classified into Spectroscopy, Chromatography, Particle Size Analysis, Capillary Electrophoresis, and Other techniques (such as calorimetry, thermal analysis, total organic carbon analysis, and FIA).